Microglia In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Microglia are the resident immune cells of the central nervous system (CNS), constituting approximately 10-15% of all brain cells. These parenchymal macrophages are derived from embryonic yolk sac progenitors and maintain self-renewal throughout life. In neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD), microglia play complex roles that can be both neuroprotective and neurotoxic. [1]
Microglia exist on a spectrum of activation states, from a homeostatic surveillance state to various activated phenotypes. In the context of neurodegeneration, key microglial states include: [2]
In Alzheimer's disease, microglia engage with amyloid-beta plaques through multiple mechanisms: [3]
Microglia in Parkinson's disease are activated by: [4]
Activated microglia in PD produce nitric oxide (NO), reactive oxygen species (ROS), and pro-inflammatory cytokines that contribute to dopaminergic neuron degeneration. [5]
Microglia in ALS and FTD exhibit both protective and toxic functions: [6]
Microglia represent promising therapeutic targets:
The study of Microglia In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Disease-associated microglia: A critical immune system in brain disorders (2024). 2024. ↩︎
Microglial activation in Parkinson's disease: Friend or foe? (2023). 2023. ↩︎
TREM2 in microglia: From biology to therapy (2023). 2023. ↩︎
The role of microglia in neurodegenerative diseases (2022). 2022. ↩︎
ALS microglia: Modulation of neuroinflammation and neurotoxicity (2023). 2023. ↩︎
Frontotemporal dementia and microglial activation (2022). 2022. ↩︎